Pro­teomics deal

Pharmacy Daily - - Front page -

ASX-LISTED clin­i­cal tri­als firm Pro­teomics In­ter­na­tional has an­nounced a new strate­gic al­liance with CPR Pharma Ser­vices, with a share swap deal which will see Pro­teomics ac­quire 10% of CPR.

The com­bined com­pa­nies will of­fer a “unique R&D fo­cused Con­tract Re­search Or­gan­i­sa­tion ca­pa­bil­ity” with project man­age­ment, cer­ti­fied bio­anal­y­sis, trial mon­i­tor­ing, sta­tis­tics and data man­age­ment and devel­op­ment of new meth­ods and di­ag­nos­tic tests.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.